Sleep aid melatonin tested as Parkinson's treatment
NCT ID NCT07375693
First seen Feb 01, 2026 · Last updated May 13, 2026 · Updated 9 times
Summary
This study tests whether taking melatonin (10 mg at bedtime) for 12 weeks can improve symptoms and reduce oxidative stress in people with mild-to-moderate Parkinson's disease who are already taking levodopa. 70 participants will be randomly assigned to receive melatonin or a placebo. The goal is to see if melatonin can ease Parkinson's symptoms beyond its known sleep benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bangladesh medical university
Dhaka, Dhaka Division, 1212, Bangladesh
Conditions
Explore the condition pages connected to this study.